Top-News

Viropharma Incorporated Aktie

Aktie
WKN:  903906 ISIN:  US9282411084
Keine aktuellen Kursdaten verfügbar
Handeln Depot/Watchlist
Dieses Wertpapier ist nicht mehr handelbar.
Aktienanzahl *
68,71 Mio.
Marktkapitalisierung *
-
Streubesitz
-
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 07.09.2012

Viropharma Incorporated News

24.01.14 - PR Newswire
Shire Successfully Completes Tender Offer for ViroPharma
Shire Successfully Completes Tender Offer for ViroPharma PR Newswire
24.01.14 - PR Newswire
Shire Successfully Completes Tender Offer for ViroPharma
Shire Successfully Completes Tender Offer for ViroPharma PR Newswire
15.01.14 - PR Newswire
Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc.
Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. PR Newswire
15.01.14 - PR Newswire
Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc.
Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. PR Newswire
10.01.14 - PR Newswire
Shire Extends Tender Offer for ViroPharma
Shire Extends Tender Offer for ViroPharma PR Newswire
10.01.14 - PR Newswire
Shire Extends Tender Offer for ViroPharma
Shire Extends Tender Offer for ViroPharma PR Newswire
27.12.13 - PR Newswire
Shire Extends Tender Offer for ViroPharma
Shire Extends Tender Offer for ViroPharma PR Newswire
27.12.13 - PR Newswire
Shire Extends Tender Offer for ViroPharma
Shire Extends Tender Offer for ViroPharma PR Newswire
11.12.13 - PR Newswire
Hart-Scott-Rodino Waiting Period Expires for Shire's Acquisition of ViroPharma
Hart-​Scott-Rodino Waiting Period Expires for Shire's Acquisition of ViroPharma PR Newswire
11.12.13 - PR Newswire
Hart-Scott-Rodino Waiting Period Expires for Shire's Acquisition of ViroPharma
Hart-​Scott-Rodino Waiting Period Expires for Shire's Acquisition of ViroPharma PR Newswire
25.11.13 - PR Newswire
VIROPHARMA INCORPORATED SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout
VIROPHARMA INCORPORATED SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout PR Newswire
21.11.13 - PR Newswire
Morgan & Morgan Announces the Investigation of ViroPharma Incorporated
Morgan & Morgan Announces the Investigation of ViroPharma Incorporated PR Newswire
13.11.13 - PR Newswire
Levi & Korsinsky, LLP Investigates ViroPharma, Inc. Board of Directors for Possible Breaches of Fiduciary Duty In Connection With Sale Of Company to Shire PLC
Levi & Korsinsky, LLP Investigates ViroPharma, Inc. Board of Directors for Possible Breaches of Fiduciary Duty In Connection With Sale Of Company to Shire PLC PR Newswire
12.11.13 - PR Newswire
Ryan & Maniskas, LLP Announces Investigation of ViroPharma Inc.
Ryan & Maniskas, LLP Announces Investigation of ViroPharma Inc. PR Newswire
12.11.13 - PR Newswire
Analysis of Pivotal Study Data Showed Routine Prevention of Hereditary Angioedema (HAE) Attacks with Cinryze® (C1 esterase inhibitor [human]) Resulted in Improved Health-Related Quality of Life Outcom
Analysis of Pivotal Study Data Showed Routine Prevention of Hereditary Angioedema (HAE) Attacks with Cinryze® (C1 esterase inhibitor [human]) Resulted in Improved Health-...
11.11.13 - PR Newswire
Harwood Feffer LLP Announces Investigation of ViroPharma, Inc.
Harwood Feffer LLP Announces Investigation of ViroPharma, Inc. PR Newswire
11.11.13 - PR Newswire
Block & Leviton LLP Investigates ViroPharma Inc. for Possible Breaches of Fiduciary Duty in Connection with Its Acquisition by Shire PLC.
Block & Leviton LLP Investigates ViroPharma Inc. for Possible Breaches of Fiduciary Duty in Connection with Its Acquisition by Shire PLC. PR Newswire
11.11.13 - PR Newswire
Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of ViroPharma, Inc.
Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of ViroPharma, Inc. PR Newswire
11.11.13 - PR Newswire
Shire to Acquire ViroPharma in Strategic Move to Strengthen Rare Disease Portfolio; Will Augment Already Strong Growth Prospects
Shire to Acquire ViroPharma in Strategic Move to Strengthen Rare Disease Portfolio; Will Augment Already Strong Growth Prospects Earnings accretive, revenue growth-​enhancing ...
11.11.13 - PR Newswire
Shire to Acquire ViroPharma in Strategic Move to Strengthen Rare Disease Portfolio; Will Augment Already Strong Growth Prospects
Shire to Acquire ViroPharma in Strategic Move to Strengthen Rare Disease Portfolio; Will Augment Already Strong Growth Prospects PR Newswire

Newssuche

Videos

newspaper
13.12.24
TRADING Insights Webinar vom 12.12.24
Themen: Aktienmarkt-​Entwicklung, Soft-​Commodities, wie Baumwolle, Kakao, Orangensaft, aber auch die ... Mehr »